Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis

被引：38

作者：

Baek, William S.

Bashey, Asad

Sheean, Geoffrey L.

机构：

[1] UCSD Perlman Ambulatory Care Ctr, Dept Neurophysiol, San Diego, CA USA

[2] Rebecca & John Moores UCSD Canc Ctr, San Diego, CA USA

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2007年 / 78卷 / 07期

关键词：

D O I：

10.1136/jnnp.2006.093567

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：771 / 771

页数：1

共 5 条

[1] Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma [J].

Gajra, A ;

Vajpayee, N ;

Grethlein, SJ .

AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (02) :196-197

[2] Successful treatment of musk antibody-positive myasthenia gravis with rituximab [J].

Hain, B ;

Jordan, K ;

Deschauer, M ;

Zierz, S .

MUSCLE & NERVE, 2006, 33 (04) :575-580

[3] Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis [J].

Monson, NL ;

Cravens, PD ;

Frohman, EM ;

Hawker, K ;

Racke, MK .

ARCHIVES OF NEUROLOGY, 2005, 62 (02) :258-264

[4] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma [J].

Takagi, K ;

Yoshida, A ;

Iwasaki, H ;

Inoue, H ;

Ueda, T .

ANNALS OF HEMATOLOGY, 2005, 84 (08) :548-550

[5] Rituximab for myasthenia gravis developing after bone marrow transplant [J].

Zaja, F ;

Russo, D ;

Fuga, G ;

Perella, G ;

Baccarani, M .

NEUROLOGY, 2000, 55 (07) :1062-1063

← 1 →